A Phase II Trial to Determine the Effect of Imetelstat (GRN163L) on Patients With Previously Treated Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Imetelstat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors Geron Corporation
- 10 Mar 2015 Status changed from suspended to completed as reported by ClinicalTrials.gov
- 20 Mar 2014 Status changed from active, no longer recruiting to suspended.
- 24 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.